A comprehensive view of amgen inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
European Patent Office Receives Amgen Inc's Patent Application for Engineered NRG-1 Variants with Improved Selectivity Toward Erbb4 But Not Against ERBB3
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Amgen Inc Submits European Patent Application for Assessing Packed Cell Volume for Cell Cultures
Published:
April 25, 2024
by Biotechnology Patent News
|
Amgen Inc. Garners Industry Recognition and Sets Employee Benefits Benchmark While Championing Innovation and Public Health Awareness
Published:
April 25, 2024
by Industry Intelligence Inc.
|
US Patent Issued to Amgen on April 23 for "ST2 antigen binding proteins" (American, Canadian Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
Amgen Inc. Prioritizes Patient Care and Environmental Sustainability with Strategic Healthcare Partnerships and Global Advocacy Grants
Published:
April 23, 2024
by Industry Intelligence Inc.
|
Ask us about our Health Care Sector market view